Mirtazap-Mepha 45, Filmtabletten - 30 Tablette(n) Swissmedic Key 61333009 Registration Holder Mepha Pharma AG Name Mirtazap-Mepha 45, Filmtabletten Date of registration 06.06.2011 Introduction of Sequence 06.06.2011 ATC-Classification Mirtazapine (N06AX11) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.06. Show package size 30 Tablette(n) Index Therapeuticus (Swissmedic) 01.06. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price 25.62 Deductible k.A. Consumer price 45.80 Feedback FB Daily cost GTIN 7680613330096 Medication Code Synthetika Pharmacode Disponibility
Composition Filmtablette: mirtazapinum 45 mg, lactosum monohydricum 339.99 mg, maydis amylum, povidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, macrogolum 6000, E 171 pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose additional_information Mirtazapine 45 mg Filmtablette
Inactive agents Dose additional_information E 171 color. Hypromellosum Überzug Lactose Monohydrate 339.99 mg Macrogol 6000 Magnesii Stearas Maydis Amylum Povidone Pro Compresso Obducto Silica Colloidalis Anhydrica
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :